Results
1
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
1 companies
Cogstate
Market Cap: AU$312.4m
A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.
CGS
AU$1.84
7D
1.1%
1Y
45.5%